Paul J. Clancy

2009

In 2009, Paul J. Clancy earned a total compensation of $2.4M as EVP and Chief Financial Officer at Biogen, a 38% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$6,456
Non-Equity Incentive Plan$279,840
Option Awards$475,884
Salary$524,231
Stock Awards$999,951
Other$101,039
Total$2,387,401

Clancy received $1M in stock awards, accounting for 42% of the total pay in 2009.

Clancy also received $6.5K of change in pension value and nonqualified deferred compensation earnings, $279.8K in non-equity incentive plan, $475.9K in option awards, $524.2K in salary and $101K in other compensation.

Rankings

In 2009, Paul J. Clancy's compensation ranked 1,970th out of 9,885 executives tracked by ExecPay. In other words, Clancy earned more than 80.1% of executives.

ClassificationRankingPercentile
All
1,970
out of 9,885
80th
Division
Manufacturing
691
out of 3,690
81st
Major group
Chemicals And Allied Products
131
out of 866
85th
Industry group
Drugs
81
out of 638
87th
Industry
Biological Products, Except Diagnostic Substances
12
out of 133
91st
Source: SEC filing on April 27, 2012.

Clancy's colleagues

We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2009.

2009

James Mullen

Biogen

Chief Executive Officer

2009

Hans Hasler

Biogen

Chief Operating Officer

2009

Robert Hamm

Biogen

Chief Operating Officer

2009

Craig Schneier

Biogen

Former EVP, HR, Public Affairs and Communications

2009

Susan Alexander

Biogen

General Counsel

You may also like